TITLE 18. PROFESSIONAL AND OCCUPATIONAL LICENSING
Title of Regulation: 18VAC110-20. Regulations
Governing the Practice of Pharmacy (amending 18VAC110-20-80, 18VAC110-20-105;
adding 18VAC110-20-22).
Statutory Authority: § 54.1-2400 of the Code of
Virginia.
Public Hearing Information:
September 25, 2018 - 9:10 a.m. - Perimeter Center, 9960 Mayland
Drive, Suite 201, Board Room 2, Richmond, VA 23233
Public Comment Deadline: November 16, 2018.
Agency Contact: Caroline Juran, RPh, Executive Director,
Board of Pharmacy, 9960 Mayland Drive, Suite 300, Richmond, VA 23233-1463,
telephone (804) 367-4456, FAX (804) 527-4472, or email
caroline.juran@dhp.virginia.gov.
Basis: Regulations are promulgated under the general
authority of Chapter 24 of Title 54.1 of the Code of Virginia. Section
54.1-2400, which provides the Board of Pharmacy the authority to promulgate
regulations to administer the regulatory system that are reasonable and
necessary to administer effectively the regulatory system.
Purpose: The purpose of the proposed regulatory action
is to streamline the licensure process and expedite National Association of
Boards of Pharmacy (NABP) reporting of demographic information, examination
scores, licensure status in all states, disciplinary history, and continuing
education. By having real-time information, the board will have greater
assurance that there are no grounds for denial of an initial or reinstatement
application for a pharmacist, a pharmacy intern, or a pharmacy technician. The
e-profile information available to the board will enhance its ability to
protect the public health and safety.
Substance: Sections relating to initial application for
licensure or registration as a pharmacist, pharmacy intern, or pharmacy
technician or for renewal of any of such license or registration are amended to
include a requirement for each such person to report an e-profile
identification number obtained from NABP.
Issues: There are no advantages or disadvantages to the
public. The advantage to the agency is the ability to expedite applications by
accessing data in a centralized location with NABP. There are no disadvantages
to the agency.
Department of Planning and Budget's Economic Impact
Analysis:
Summary of the Proposed Amendments to Regulation. The Board of
Pharmacy (Board) proposes to require individuals applying for initial
pharmacist licensure, pharmacist license renewal, pharmacist license
reinstatement, pharmacy intern registration, initial pharmacy technician
registration, pharmacy technician registration renewal, or pharmacy technician
registration reinstatement, to provide their e-profile identification number
(e-profile ID) from the National Association of Boards of Pharmacy (NABP) in
their application.
Result of Analysis. The benefits likely exceed the costs for
all proposed changes.
Estimated Economic Impact.
Background. NABP is a 501(c)(3) nonprofit association that
protects public health by assisting its member boards of pharmacy and offers
programs that promote safe pharmacy practices for the benefit of consumers. The
e-profile ID is provided through the CPE Monitor Service, a collaborative
effort of NABP, the Accreditation Council for Pharmacy Education (ACPE), and
ACPE-accredited providers. The CPE Monitor Service allows electronic tracking
of continuing pharmacy education (CPE) credits from ACPE-accredited providers.
The NABP assigns an e-profile ID through the CPE Monitor Service to applicants
so they can track credits, apply to sit for an exam, monitor continuing education,
verify licensure, etc.
Analysis. Most pharmacists, technicians, and interns already
possess an e-profile ID since it is assigned anytime an NABP service is first
used, e.g., examination, CPE monitoring, licensure by endorsement, etc.1
There is no charge to acquire an e-profile ID, and it is already required to be
approved to sit for the licensure examination or to receive NABP-approved CPE.
The Department of Health Professions (DHP) indicates that
requiring the e-profile ID may decrease its administrative burden when
communicating with the NABP, and may reduce the possible chance of error when
using the applicant's name or a breach of confidentiality occurring as a result
of using other methods of identifying applicants such as the social security
number. The applicant's name is currently used to obtain exam scores, but the
e-profile ID is used to verify CPE credits when it is available. According to
DHP, there have been instances in other states where personal information, such
as the social security number, has been released as the result of a data
breach; this situation could have been avoided if the e-profile ID had been
used in its place. Given the potential reduction in administrative costs,
errors, or breach of confidentiality, and the lack of cost acquiring an
e-profile ID, the proposed amendment should produce a net benefit.
Businesses and Entities Affected. The proposed amendments would
apply to the 14,714 licensed pharmacists, 14,662 registered pharmacy
technicians, and 1,848 registered pharmacy interns in the Commonwealth, as well
as future applicants. In 2017, 854 pharmacists were newly licensed, 2,017
pharmacy technicians were newly registered, and 591 pharmacy interns were newly
registered.2
Localities Particularly Affected. The proposed amendments do
not disproportionately affect particular localities.
Projected Impact on Employment. The proposed amendments would
not significantly affect employment.
Effects on the Use and Value of Private Property. The proposed
amendments do not significantly affect the use and value of private property.
Real Estate Development Costs. The proposed amendments do not
affect real estate development costs.
Small Businesses:
Definition. Pursuant to § 2.2-4007.04 of the Code of Virginia,
small business is defined as "a business entity, including its affiliates,
that (i) is independently owned and operated and (ii) employs fewer than 500
full-time employees or has gross annual sales of less than $6 million."
Costs and Other Effects. The proposed amendments would not
significantly affect costs for small businesses.
Alternative Method that Minimizes Adverse Impact. The proposed
amendments would not adversely affect small businesses.
Adverse Impacts:
Businesses. The proposed amendments would not adversely affect
businesses.
Localities. The proposed amendments would not adversely affect
localities.
Other Entities. The proposed amendments would not adversely
affect other entities.
_______________________________________
1Source: Department of Health Professions
2Data source: Department of Health Professions
Agency's Response to Economic Impact Analysis: The Board
of Pharmacy concurs with the analysis of the Department of Planning and Budget.
Summary:
The proposed amendments require a pharmacist, pharmacy intern,
or pharmacy technician applicant to provide an e-profile identification number
from the National Association of Boards of Pharmacy in an application for a
license, registration, and renewal or reinstatement of license or registration.
18VAC110-20-22. Application to include e-profile number.
An application for licensure as a pharmacist by
examination or endorsement or for registration as a pharmacy intern or pharmacy
technician shall include an e-profile number issued by NABP.
18VAC110-20-80. Renewal and reinstatement of license.
A. Pharmacist licenses expire on December 31 and shall be
renewed annually prior to that date by the submission of a renewal fee, renewal
form, an e-profile number issued by NABP, and statement of compliance
with continuing education requirements.
B. A pharmacist newly licensed on or after October 1 shall
not be required to renew that license until December 31 of the following year.
C. A pharmacist who fails to renew his license by the
expiration date may renew his license at any time within one year of its
expiration by submission of the renewal fee and late fee, renewal form, and
statement of compliance with continuing education requirements.
D. A pharmacist who fails to renew his license for more than
one year following expiration and who wishes to reinstate such license shall
submit an application for reinstatement, pay the current renewal fee and a
reinstatement fee, and submit documentation showing compliance with continuing
education requirements. Reinstatement is at the discretion of the board and may
be granted by the executive director of the board provided no grounds exist to
deny said reinstatement.
E. A pharmacist who has been registered as inactive for more
than one year must apply for reinstatement, submit documentation showing
compliance with continuing education requirements, and pay the current year
active renewal fee in order to resume active licensure.
F. In order to reactivate or reinstate a license to active
status, a pharmacist who holds an inactive license, who has allowed his license
to lapse, or who has had his license suspended or revoked must submit evidence
of completion of CEU's or hours equal to the requirements for the number of
years in which his license has not been active, not to exceed a total of 60
hours of CE.
G. A pharmacist whose license has been lapsed, in inactive
status, or suspended or revoked for more than five years shall, as a condition
of reinstatement in addition to 60 hours CE, take and receive a passing score
on the board-approved law examination and furnish acceptable documentation of
one of the following:
1. Active pharmacy practice within the past five years as a
properly licensed pharmacist in another state; or
2. Practical experience as a pharmacy intern registered with
the board of at least 160 hours within six months immediately prior to being
reinstated.
H. The practice of pharmacy without a current, active
pharmacist license is unlawful and shall constitute grounds for disciplinary
action by the board.
I. It shall be the duty and responsibility of each licensee
to inform the board of his current address. A licensee shall notify the board
within 14 days in writing or electronically of any change of an address of
record. Properly updating address of record directly through the board's
web-based application or other approved means shall constitute lawful
notification. All notices required by law or by these rules and regulations are
deemed to be legally given when mailed to the address of record and shall not
relieve the licensee of the obligation to comply.
18VAC110-20-105. Renewal and reinstatement of registration.
A. Pharmacy technician registrations expire on December 31
and shall be renewed annually prior to that date by the submission of a renewal
fee, and renewal form, and an e-profile number issued by NABP. A
pharmacy technician newly registered on or after July 1 shall not be required
to renew that registration until December 31 of the following year. Failure to
receive the application for renewal shall not relieve the pharmacy technician
of the responsibility for renewing the registration by the expiration date.
B. A pharmacy technician who fails to renew his registration
by the expiration date may renew his registration at any time within one year
of its expiration by submission of the renewal fee and late fee, renewal form,
and attestation of having obtained required continuing education.
C. A pharmacy technician who fails to renew his registration
for more than one year following expiration and who wishes to reinstate such
registration shall submit an application for reinstatement, pay the current
renewal fee and a reinstatement fee, and submit documentation showing compliance
with continuing education requirements. Reinstatement is at the discretion of
the board and may be granted by the executive director of the board provided no
grounds exist to deny said reinstatement. Conducting tasks associated with a
pharmacy technician with a lapsed registration shall be illegal and may subject
the registrant to disciplinary action by the board.
D. A person who fails to reinstate a pharmacy technician
registration within five years of expiration, shall not be eligible for reinstatement
and shall repeat an approved training program and repeat and pass the
examination, or hold current PTCB certification, before applying to be
reregistered.
VA.R. Doc. No. R18-5278; Filed August 15, 2018, 3:37 p.m.